These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer's disease. Ota M; Matsuo J; Ishida I; Takano H; Yokoi Y; Hori H; Yoshida S; Ashida K; Nakamura K; Takahashi T; Kunugi H Neurosci Lett; 2019 Jan; 690():232-236. PubMed ID: 30367958 [TBL] [Abstract][Full Text] [Related]
13. The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review. Dewsbury LS; Lim CK; Steiner GZ Adv Nutr; 2021 Jul; 12(4):1571-1593. PubMed ID: 33621313 [TBL] [Abstract][Full Text] [Related]
14. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease. Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809 [TBL] [Abstract][Full Text] [Related]
15. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. Nagpal R; Neth BJ; Wang S; Craft S; Yadav H EBioMedicine; 2019 Sep; 47():529-542. PubMed ID: 31477562 [TBL] [Abstract][Full Text] [Related]
16. Mild cognitive impairment: when nutrition helps brain energy rescue-a report from the EuGMS 2020 Congress. Cunnane SC; Sieber CC; Swerdlow RH; Cruz-Jentoft AJ Eur Geriatr Med; 2021 Dec; 12(6):1285-1292. PubMed ID: 34227053 [TBL] [Abstract][Full Text] [Related]
17. The Role of Ketogenic Diet in the Treatment of Neurological Diseases. Dyńka D; Kowalcze K; Paziewska A Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501033 [TBL] [Abstract][Full Text] [Related]
18. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases. Jensen NJ; Wodschow HZ; Nilsson M; Rungby J Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502 [TBL] [Abstract][Full Text] [Related]
19. Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease. King E; O'Brien J; Donaghy P; Williams-Gray CH; Lawson RA; Morris CM; Barnett N; Olsen K; Martin-Ruiz C; Burn D; Yarnall AJ; Taylor JP; Duncan G; Khoo TK; Thomas A Int J Geriatr Psychiatry; 2019 Aug; 34(8):1244-1250. PubMed ID: 30993722 [TBL] [Abstract][Full Text] [Related]
20. Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study. Nagpal R; Neth BJ; Wang S; Mishra SP; Craft S; Yadav H EBioMedicine; 2020 Sep; 59():102950. PubMed ID: 32861197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]